- Home
- NVCR vs NMFC Comparison
NVCR vs NMFC Comparison
Compare NVCR & NMFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- NMFC
- Stock Information
- Founded
- NVCR 2000
- NMFC 2010
- Country
- NVCR Switzerland
- NMFC United States
- Employees
- NVCR N/A
- NMFC N/A
- Industry
- NVCR Medical/Dental Instruments
- NMFC Finance/Investors Services
- Sector
- NVCR Health Care
- NMFC Finance
- Exchange
- NVCR Nasdaq
- NMFC Nasdaq
- Market Cap
- NVCR 1.4B
- NMFC 1.2B
- IPO Year
- NVCR 2015
- NMFC 2011
- Fundamental
- Price
- NVCR $12.43
- NMFC $10.39
- Analyst Decision
- NVCR Buy
- NMFC Hold
- Analyst Count
- NVCR 7
- NMFC 2
- Target Price
- NVCR $28.79
- NMFC $10.50
- AVG Volume (30 Days)
- NVCR 1.9M
- NMFC 457.2K
- Earning Date
- NVCR 07-24-2025
- NMFC 08-04-2025
- Dividend Yield
- NVCR N/A
- NMFC 12.31%
- EPS Growth
- NVCR N/A
- NMFC N/A
- EPS
- NVCR N/A
- NMFC 0.77
- Revenue
- NVCR $630,160,000.00
- NMFC $355,675,000.00
- Revenue This Year
- NVCR $6.68
- NMFC N/A
- Revenue Next Year
- NVCR $7.01
- NMFC N/A
- P/E Ratio
- NVCR N/A
- NMFC $13.55
- Revenue Growth
- NVCR 14.58
- NMFC N/A
- 52 Week Low
- NVCR $10.87
- NMFC $8.84
- 52 Week High
- NVCR $34.13
- NMFC $12.45
- Technical
- Relative Strength Index (RSI)
- NVCR 46.30
- NMFC 48.52
- Support Level
- NVCR $11.55
- NMFC $10.30
- Resistance Level
- NVCR $12.26
- NMFC $10.47
- Average True Range (ATR)
- NVCR 0.46
- NMFC 0.17
- MACD
- NVCR 0.30
- NMFC 0.01
- Stochastic Oscillator
- NVCR 97.50
- NMFC 86.36
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About NMFC New Mountain Finance Corporation
New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds and mezzanine securities.